According to the plaintiffs in the suit against Express Scripts: Grasso Enterprises, LLC, d/b/a Annie’s Apothecary, NERxD, LLC, d/b/a Cypress Compounding Pharmacy, and Wiley’s Pharmacy and Compounding Services, Inc., filed by their attorneys Quadrino Law Group, P.C. and The Simon Law Firm, P.C., claim “Express Scripts (“ESI”), has recently embarked upon a scheme to deny all claims under health plans seeking payment for “compound” pharmaceutical medications”. According to the complaint, Compounded medicines are customized pharmaceuticals made according to specific prescriptions, written by physicians, where no appropriate alternatives are mass-produced or commercially available. Health plan claims for these compounded medicines have, up to last year, been routinely paid by Express Scripts directly to in network compound pharmacies.
Announcing a brand new hybrid dispensing model that focuses on the way your practice prescribes weight loss products, the MedX Sales Weight Loss Dispensing Program.
MedX Sales has been a leader in the dispensing industry for years, providing pre-packaged medicines to medical practices via relationships with multiple DEA licensed pharmaceutical repackagers. Today, MedX Sales is introducing a new hybrid dispensing model that will significantly reduce weight loss clinic costs, increasing profit by tens or even hundreds of thousands of dollars annually.
What was that, “soup to nuts” you ask?
Gary Silbiger, the President of MedX Sales, LLC, has always said that about his company’s dispensing program, that it takes care of everything, “soup to nuts”. I have always wondered what the relationship was between soup and nuts, but thats not the point I am making here.